Localization in clinical neurology
Dr Saad Shafqat is incorrect in his assertion that localization in clinical neurology has been rendered outmoded by advances in technology. 1 The advances of modern neurology are built on the assumption that the neurologist can make the correct diagnosis. We were present when one of the first computerized tomography scans of the brain was performed in the 1970s. Upon seeing these first clear images of the brain, Dr Raymond Adams declared that we were witnessing the introduction of a new tool into clinical neurology. That has certainly proved to be true, but imaging is still just a tool. The treatments for neurological disease that we now possess are also not ends in themselves. They are only part of the continuous, gradual development of knowledge about the nervous system needed to solve the really big problems in clinical neurology (e.g. epilepsy, paralysis, dementia, neoplasia, degenerative disease, and stroke).
The fundamental problem that arises in degrading the examination is that all clinical analyses risk starting from the wrong point. Mistaking weakness for ataxia, tremor for seizure, functional paralysis for genuine paralysis, root pattern sensory loss from that of nerve or spinal cord, aphasia from psychosis, dystonia from joint limitation, coma from catatonia, hip arthritis from lumbar radiculopathy, apraxia from confusion: not to mention distinguishing the various types of gait and dysarthrias, create endless and misplaced testing, the results of which are as useful as the original mistake in interpretation.
In our current practices, much of what we do is to take a careful history, examine the patient and put into proper perspective all of the imaging, genetic and other laboratory testing that may or may not bear on the patient's problem. Experienced experts can learn to apply the principles correctly yet rapidly in order to conform to the time D Summerfield (March 2006 JRSM 1 ) reports that the epidemiology of depression is difficult as emotion is understood differently in Eastern and Western cultures.
Emotion is a word that presents difficulty for us all. The Concise Oxford Dictionary records the word emotion as originating in the 16th century replacing the older word passion and that it is from the French émouvoir, to excite.
The taxonomy of emotions presents many difficulties; in 1872 Darwin 2 wrote only of emotional expression in man and animals. Shand in 1869 3 noted that sentiments were groups of emotions dependant on the environment. If one loved a person and something good happened to them, one was happy; if something adverse occurred, sadness resulted.
A further refinement was suggested by McDougall, 4 who in 1905 stated that moods were a tendency to primary emotion, e.g. rage or fear. Much was written in the 20th century about the lmbic system and emotion. Attempts were also made to divide emotions into primary, blended and derived-the latter are not shared with animals as they are constructed by cognitive functions.
A current view has been expressed by Carpenter, 5 who suggests that there are two basic emotions in man and animal-arousal and withdrawal. Arousal is associated with 'fight or flight' and the sympathetic system: withdrawal is associated with a range of depressive states.
It seems that human behaviour, as with other sciences, needs its own specific-a subject discussed by C P Snow (The Two Cultures. Cambridge University Press). The choice of either sotalol or amiodarone for rhythm control was a feature of the management of a case presented by Leaver and Ho (March 2006 JRSM 1 ) which was even more problematic than the inadvertent choice of adversely interacting drugs. Although amiodarone was the final choice of antiarrhythmic agent, presumably because of its superior efficacy in preventing relapse of atrial fibrillation (AF), 2 it is a drug now known to be associated with relapse rates of the order of 490%. 3, 4 Accordingly, so long as the long-term antiarrhythmic management of AF involves drugs, which are not strikingly superior to amiodarone in their efficacyeven with the benefit of adjunctive electrical cardioversion 3 -the verdict from the AFFIRM study 5 will prevail. In paraphrase, the verdict from AFFIRM is that failed rhythm control is a poor substitute for successful rate control.
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